Contemporary OB/GYN

Directions Website

Contemporary OB/GYN Expert advice for today’s ob-gyn.

Welcome to November! Get caught up on all of our top  , guidelines, and other women's health news with our October recap...
11/02/2026

Welcome to November!

Get caught up on all of our top , guidelines, and other women's health news with our October recap article, all in one place.

Top headlines from October: https://hubs.li/Q04D0Ns20

ICYMI: The FDA last week granted accelerated approval to doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd (V...
11/02/2026

ICYMI:

The FDA last week granted accelerated approval to doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd (Voceryq; INOVIO) to reduce the frequency of surgical papilloma excisions in adults with recurrent respiratory papillomatosis (RRP).

Children can acquire HPV from their mother during vaginal delivery when active ge***al warts are present, and occasionally during cesarean delivery, suggesting the virus can reach the fetus before birth.

More: https://hubs.li/Q04D0C600

11/01/2026

In our Sunday Spotlight video of the week, Chrisandra L. Shufelt, MD, MS, FACP, MSCP, professor and chair of the Division of General Internal Medicine and associate director of the Women’s Health Research Center at Mayo Clinic in Jacksonville, Florida, joined Contemporary OB/GYN at The Menopause Society Annual Meeting 2026 in San Diego, California, to discuss how cardiovascular risk can play a role in menopause care and hormone therapy consideration.

WATCH:

News from the  :The federal agency approved updated labeling for 3 additional estradiol transdermal patches, removing ca...
10/30/2026

News from the :

The federal agency approved updated labeling for 3 additional estradiol transdermal patches, removing cardiovascular disease, breast cancer, and probable dementia statements from their boxed warnings.

With label approvals for 6 menopausal hormone therapy products in February and 3 more this week, 29 drug companies have submitted proposed labeling changes to the FDA.

MORE: https://hubs.li/Q04CWPdq0

10/29/2026

In another segment with Susan Reed, MD, MPH, MS, professor emeritus of obstetrics and gynecology at the University of Washington, we discuss the future needs for clinical trials and studies.

Watch our full interview from The Menopause Society Annual Meeting here: https://hubs.li/Q04CQSNn0

10/29/2026

Thank you, Matthew Nudy, MD, for speaking with us at Annual Meeting about cardiovascular health opportunities that overlap with ob-gyn care.

Learn much more about this topic in our full discussion with Dr. Nudy, here: https://hubs.li/Q04CQ2TM0

If you missed it:   issued a practice advisory recommending that ob-gyns advise against   receptor agonist use during   ...
10/28/2026

If you missed it:

issued a practice advisory recommending that ob-gyns advise against receptor agonist use during and counsel patients to consider discontinuation 1 to 2 months before conception.

Lead author of the practice advisory D. Yvette LaCoursiere, MD, FACOG, comments on the limited available safety data and ability for GLP-1 access.

Read highlights from the full practice advisory here: https://hubs.li/Q04CC4tX0

New multisociety guidance treats menstrual patterns as a female-specific vital sign and recognizes adverse pregnancy out...
10/27/2026

New multisociety guidance treats menstrual patterns as a female-specific vital sign and recognizes adverse pregnancy outcomes as risk enhancers.

ACOG President Camille A. Clare, MD, MPH, said the new guidance examines heart health from childhood onward to help clinicians identify women’s cardiovascular risk early. Camille A. C.

Societies in the new framework include:

- American Heart Association
- American College of Obstetricians & Gynecologists - ACOG
- The Society for Maternal-Fetal Medicine
- American Academy of Pediatrics

Learn more here: https://hubs.li/Q04Ctkr80

10/27/2026

Behind the scenes at ! 🎥

Our Contemporary OB/GYN editorial team was on the ground in San Diego for The Menopause Society's 2026 Annual Meeting, connecting with experts to explore the latest research and clinical advances in menopause and midlife women’s health.

From hormone therapy and cardiovascular health to mental health, sexual health, and emerging treatment options, the meeting highlighted key topics shaping menopause care.

Take a look behind the scenes and explore our coverage for expert perspectives and key takeaways from !

🔗 Full coverage here: https://hubs.li/Q04CsdDl0

We are thrilled to share the inaugural episode of our new series, Mind, Body, & The Pause, hosted by Dr. Soma Mandal, in...
10/26/2026

We are thrilled to share the inaugural episode of our new series, Mind, Body, & The Pause, hosted by Dr. Soma Mandal, in collaboration with Hackensack Meridian Health!

In this first episode, Mandal is joined by guests Manisha Parulekar, MD, AGSF, FACP, CMD, and Jocelyn Carlo, MD, to discuss , brain fog, and screening gaps in care.

Join us for the first episode of our Perimenopause and Beyond series here: https://hubs.li/Q04CnD6f0

Address

25115 Country Club Boulevard
North Olmsted, OH
44070

Alerts

Be the first to know and let us send you an email when Contemporary OB/GYN posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Nearby clinics